Know Cancer

or
forgot password

Phase III Study of the Treatment of Genital Warts by Low Dose Cyclophosphamide


Phase 3
18 Years
60 Years
Not Enrolling
Both
Genital Wart

Thank you

Trial Information

Phase III Study of the Treatment of Genital Warts by Low Dose Cyclophosphamide


Patients were first treated with CO2 laser therapy, and then treated with low-dose CY,
orally 50 mg per day for 7 days.The CA recurrence were observed.


Inclusion Criteria:



- Clinical diagnosis of large genital warts

Exclusion Criteria:

- HPV type 6 or 11 was detected negatively by PCR method.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Outcome Measure:

low-dose cyclophosphamide effectively prevents the recurrence of large genital warts after laser therapy

Outcome Time Frame:

6 month

Safety Issue:

Yes

Principal Investigator

Bo Huang, PH.D, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Tongji Medical College

Authority:

China: Ministry of Health

Study ID:

Sheng-Qi-An

NCT ID:

NCT00999986

Start Date:

January 2007

Completion Date:

August 2009

Related Keywords:

  • Genital Wart
  • Condylomata Acuminata
  • Warts

Name

Location